SPEED DIRO

Informazioni principali

  • Nome commerciale:
  • SPEED DIRO
  • Confezione:
  • Scatola da 6 test
  • Tipo di ricetta:
  • Libera vendita
  • Utilizzare per:
  • Animali
  • Tipo di medicina:
  • Dispositivo medico

Documenti

  • per i professionisti:
  • Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.


    Richiedi il foglio illustrativo per i professionisti.

Localizzazione

  • Disponibile in:
  • SPEED DIRO
    Italia
  • Lingua:
  • italiano

Informazioni terapeutiche

  • Gruppo terapeutico:
  • Cani
  • Area terapeutica:
  • Tutti gli altri prodotti non terapeutici
  • Indicazioni terapeutiche:
  • Diagnosi rapida per la ricerca degli antigeni circolanti della filaria Dirofilaria immitis su siero, plasma o sangue intero con anticoagulante.
  • Dettagli prodotto:
  • Posologia: Con una pipetta mantenuta in posizione verticale, deporre una goccia del campione nel pozzetto. Deporre 5 gocce di REAGENTE nel pozzetto. Tempo di lettura: 15 minuti di migrazione.

Altre informazioni

Status

  • Fonte:
  • Ministero della Salute - Italia
  • Numero dell'autorizzazione:
  • 920339165
  • Ultimo aggiornamento:
  • 14-08-2017

Foglio illustrativo: composizione, posologia, indicazioni, interazioni, gravidanza, allattamento, effetti indesiderati, controindicazioni

Speed Diro

Q INTERESSE CLINICO

LHKPYVÄSHYPVZPJHYKPVWVSTVUHYLu\U»LSTPU[VZPKV]\[HHSSHWYLZLUaH

L HSSV Z]PS\WWV ULSSL HY[LYPL WVSTVUHYP L PU ZLN\P[V ULS ]LU[YPJVSV

JHYKPHJVKLZ[YVKP\UHÄSHYPH+PYVÄSHYPHPTTP[PZ8\LZ[VWHYHZZP[H

JVSWPZJLPSJHULL[HS]VS[HPSNH[[VLKu[YHZTLZZVVIISPNH[VYPHTLU[L

KHSSHW\U[\YHKP\UHaHUaHYH

0SZVZWL[[VJSPUPJVZPIHZHZVWYH[[\[[VZ\SSHMHJPSP[nKPHMMH[PJHTLU[V

KLS JHUL Z\ [VZZL JHYKPHJH TVYTVYPV JHYKPHJV L KPZWULH 3H

YPJLYJH

KLNSP

HU[PNLUP

JPYJVSHU[P

KLP

]LYTP

HK\S[P

WLYTL[[L

L]PKLUaPHYL S»PUMLZ[HaPVUL JVU \U»LJJLSSLU[L ZLUZPIPSP[n 8\LZ[H

YPJLYJHWLYTL[[LHUJOLKPL]PKLUaPHYLKPYVÄSHYPVZPVJJ\S[LPUJ\P]P

uHZZLUaHKPTPJYVÄSHYPLJPYJVSHU[P KLPJHZP

:WLLK+PYVWLYTL[[L!

- KP L]PKLUaPHYL NSP HU[PNLUP JPYJVSHU[P KP +PYVÄSHYPH PTTP[PZ JOL

ZVUV JHYH[[LYPZ[PJP KLSSH WYLZLUaH KP ]LYTP HK\S[P ULSS»HWWHYH[V

JPYJVSH[VYPVKLSS»HUPTHSL

KPH]]PHYLLWYVZLN\PYL\U[YH[[HTLU[VHK\S[PJPKH

KPJVUK\YYL\U[YH[[HTLU[VWYL]LU[P]V

Q PRINCIPIO

:WLLK +PYV u \U [LZ[ X\HSP[H[P]V YHWPKV IHZH[V Z\S WYPUJPWPV

KLSS»PTT\UVJYVTH[VNYHÄHZ\TLTIYHUHJOLWLYTL[[LKPTL[[LYL

PUL]PKLUaHSHWYLZLUaHKPHU[PNLUPJPYJVSHU[PKP+PYVÄSHYPHPTTP[PZ

7LYVNUP[LZ[uZ\MÄJPLU[LKLWVYYL\UHNVJJPHKLSJHTWPVULZPLYV

IT-1

Speed Diro

Kit di diagnosi veterinaria

Solo per uso in vitro

WSHZTH V ZHUN\L PU[LYV JVU HU[PJVHN\SHU[L ULS WVaaL[[V KLS

JHTWPVUL <UH ]VS[H KLWVZ[V PS JHTWPVUL SL WHY[PJLSSL JVSVYH[L

KLS

JVUP\NH[V

SLNHUV

HNSP

HU[PNLUP

JPYJVSHU[P

+PYVÄSHYPH

PTTP[PZ 0 JVTWSLZZP JVUP\NH[VHU[PNLUP JVZy MVYTH[P TPNYHUV WLY

JHWPSSHYP[n Z\SSH TLTIYHUH=LUNVUV X\PUKP JH[[\YH[P KH HU[PJVYWP

ZWLJPÄJP

ÄZZH[P

Z\SSH

TLTIYHUH

MVYTHUV

WLY

HJJ\T\SV

WHY[PJLSSLJVSVYH[L\UHIHUKH[LZ[KPJVSVYLYVZH3»PUZPLTLTPNYH

Z\SZ\WWVY[VÄUVHYHNNP\UNLYLS»LZ[YLTP[nKLSSHTLTIYHUHKV]LSL

WHY[PJLSSLJVSVYH[LYPTHULU[PMVYTHUV\UHIHUKHKPJVU[YVSSVYVZH

JOLJVUMLYTHSHJVYYL[[HLZLJ\aPVULKLS[LZ[

Q PROTOCOLLO OPERATIVO

PER OGNI TEST PREVEDERE:

JLSSH[LZ[WPWL[[HTVUV\ZVPSÅHJVULKPYLHNLU[L

<[PSPaaHYLPYLHNLU[PH[LTWLYH[\YHHTIPLU[L

Non mescolare mai reagenti di lotti diversi.

1/ DEPOSITO DEL CAMPIONE:

:PLYVWSHZTHZHUN\LPU[LYVJVUHU[PJVHN\SHU[L,+;(VLWHYPUH!

JVU

\UH

WPWL[[H

TVUV\ZV

THU[LU\[H

WVZPaPVUL

]LY[PJHSL

deporre 1 gocciaKPJHTWPVULULSWVaaL[[VKLSJHTWPVUL

2/ DEPOSITO DEL REAGENTE:

 (NNP\UNLYL PS YLHNLU[L Z\IP[V KVWV H]LY KLWVZ[V PS JHTWPVUL

4HU[LULYL

ÅHJVUL

YLHNLU[L

WVZPaPVUL

]LY[PJHSL

aggiungerne 5 gocceULSWVaaL[[VKLSJHTWPVUL

  :L SL TPNYHaPVUL UVU PUPaPH LU[YV  TPU\[P aggiungere altre

2 gocceKPYLHNLU[LULSWVaaL[[VKLSJHTWPVUL

IT-2

3/ LETTURA E INTERPRETAZIONE DEI RISULTATI:

3LNNLYLPSYPZ\S[H[VKVWV15 minuti di migrazione!

:LPSTEST È NEGATIVOJVTWHYL1 banda rosaULSSH

ÄULZ[YHKPSL[[\YHIHUKHKPJVU[YVSSV

:LPSTEST È POSITIVO compaiono 2 bande rosaILU

KPZ[PU[L ULSSH ÄULZ[YH KP SL[[\YH IHUKH [LZ[  IHUKH KP

JVU[YVSSV

3HJVTWHYZHKP\UHIHUKH[LZ[KVWVZVSVTPU\[PKP

TPNYHaPVULWLYTL[[LKPJVUJS\KLYLJOLPS[LZ[uWVZP[P]V

<UH JVSVYHaPVUL HUJOL TVS[V SPL]L KLSSH IHUKH [LZ[

KL]LLZZLYLJVUZPKLYH[HJVTL\UYPZ\S[H[VWVZP[P]V

- 3»HZZLUaHKLSSHIHUKHKPJVU[YVSSVZPNUPÄJHJOLPS[LZ[

non è valido.

Q RACCOMANDAZIONI

‹STABILITÀ / CONSERVAZIONE:

 

TLZP

[LTWLYH[\YH

HTIPLU[L

WHY[PYL

KHSSH

KH[H

MHIIYPJHaPVUL3HKH[HKPZJHKLUaHuYPWVY[H[HZ\SRP[LZ\VNUPI\Z[H

JVU[LULU[LP[LZ[

  *VUZLY]HYL H [LTWLYH[\YH HTIPLU[L [YH ‡* L ‡* 5VU

LZWVYYLPS[LZ[H[LTWLYH[\YL[YVWWVLSL]H[LVPUMLYPVYPH‡*

‹CAMPIONI :

 0JHTWPVUPKPZPLYVWSHZTHVZHUN\LPU[LYVJVUHU[PJVHN\SHU[L

KL]VUV[YV]HYZPH[LTWLYH[\YHHTIPLU[LHSTVTLU[VKLSS»\[PSPaaV

  *VUZLY]HaPVUL KLP JHTWPVUP ÄUV H  VYL! JVUZLY]HYL ZPLYV

WSHZTHVZHUN\LPU[LYVJVUHU[PJVHN\SHU[LH[LTWLYH[\YHHTIPLU[L

  *VUZLY]HaPVUL KLP JHTWPVUP ÄUV H  VYL! JVUZLY]HYL ZPLYV V

WSHZTH[YH‡*L‡*PUMYPNVYPMLYV3HJVUZLY]HaPVULKLSZHUN\L

IT-3

PU[LYV WLY KP]LYZL VYL [YH ‡* L ‡* W\~ WYV]VJHYL \U»LTVSPZP

WHYaPHSLUVU]PZPIPSLHVJJOPVU\KVJOLW\~YLUKLYLWPƒKPMÄJPSL

S»PU[LYWYL[HaPVULKLS[LZ[

 6S[YLSLVYLJVUZLY]HYLZPLYVLWSHZTHH‡*5VUJVUNLSHYL

THP\UJHTWPVULKPZHUN\LPU[LYV

‹PRECAUZIONI PER LA MANIPOLAZIONE :

  7LY V[[LULYL \UH TPNYHaPVUL JVYYL[[H KLS JHTWPVUL TL[[LYL SH

JLSSH[LZ[Z\\UHZ\WLYÄJPLWPHUHLVYPaaVU[HSL

 7LYZ[HUKHYKPaaHYLSHX\HU[P[nKPJHTWPVULULJLZZHYPHWLYJPHZJ\U

[LZ[\[PSPaaHYLLZJS\ZP]HTLU[LSLWPWL[[LWYLZLU[PULSSHJVUMLaPVUL

 7LYKLWVYYLJVYYL[[HTLU[LPSJHTWPVULLPSYLHNLU[LTHU[LULYLPS

ÅHJVULJVU[HNVJJLKLSYLHNLU[LLSHWPWL[[HPUWVZPaPVUL]LY[PJHSL

‹ALTRE RACCOMANDAZIONI :

 +\YHU[LS»LZLJ\aPVULKLS[LZ[SHÄULZ[YHKPSL[[\YHW\~TVZ[YHYL

\UHSPL]LJVSVYHaPVULYVZHJOLUVUOHHSJ\UHJVUZLN\LUaHZ\SSH

X\HSP[nKLSYPZ\S[H[V

- Non mescolare reagenti di lotti diversi.

  3HZJPHYL JOL P YLHNLU[P YHNNP\UNHUV SH [LTWLYH[\YH HTIPLU[L

WYPTHKLSS»\ZV

 <[PSPaaHYL\UHU\V]HWPWL[[HTVUV\ZVWLYVNUP[LZ[

8\LZ[L YHJJVTHUKHaPVUP JVZ[P[\PZJVUV ZVSV \UH N\PKH PU X\HU[V

UVUZPW\~WYL[LUKLYLJOLHSJ\UTL[VKVKPHNUVZ[PJVZPHWYLJPZVHS

 3VZJVWVKPX\LZ[V[LZ[uHP\[HYLPS]L[LYPUHYPVHKPHNUVZ[PJHYL

SH KPYVÄSHYPVZP TLKPHU[L YPSL]HTLU[V KLNSP HU[PNLUP JPYJVSHU[P KP

+PYVÄSHYPHPTTP[PZ3»PU[LYWYL[HaPVULKLS[LZ[KHWHY[LKLS]L[LYPUHYPV

KV]Yn

ZLTWYL

[LULYL

JVU[V

KLSS»HUHTULZP

KLSS»LZHTL

JSPUPJV

KLSS»HUPTHSLLKLSYPZ\S[H[VKPL]LU[\HSPHS[YPLZHTPJVTWSLTLU[HYP

3HKPHNUVZPÄUHSLYLZ[H\UHWYLYVNH[P]HKLS]L[LYPUHYPVJ\YHU[LLKu

ZV[[VSHZ\HYLZWVUZHIPSP[n

)PV =L[V ;LZ[

Z\VP

KPZ[YPI\[VYP

UVU

WVZZVUV

LZZLYL

YP[LU\[P

YLZWVUZHIPSP KLSSL JVUZLN\LUaL SLNH[L H \U \[PSPaaV ZJVYYL[[V V H

\U»PU[LYWYL[HaPVULZJVYYL[[HKLPYPZ\S[H[PMVYUP[PKHX\LZ[V[LZ[

IT-4

17-1-2019

SRAM recalls three-speed internal gear hub with coaster brake

SRAM recalls three-speed internal gear hub with coaster brake

The brake can fail, posing a crash or fall hazard to the rider.

Health Canada

10-1-2019

Stanley Black & Decker Canada Corp. recalls DEWALT DWD110 and DWD112 variable speed reversing drills

Stanley Black & Decker Canada Corp. recalls DEWALT DWD110 and DWD112 variable speed reversing drills

The internal wiring of the DEWALT 3/8-inch variable speed reversing drills can come into contact with internal parts, posing a risk of electrical shock.

Health Canada

23-8-2018

The Manhattan Toy Company recalls Pull-Back Speedy Jets

The Manhattan Toy Company recalls Pull-Back Speedy Jets

The rubber tires can separate from the wheels posing a small parts choking hazard for small children.

Health Canada

20-6-2018

Bumbleride Inc recalls Bumbleride Speed 3-wheel jogging stroller

Bumbleride Inc recalls Bumbleride Speed 3-wheel jogging stroller

Health Canada's sampling and evaluation program has determined that this jogging stroller does not meet the sharp edge requirements of the Carriages and Strollers Regulations in Canada. The metal edge of the back hinge located on the right side of the jogging stroller can be sharp, posing a potential risk of cut or laceration.

Health Canada

22-7-2018

We'll consider regulatory options to speed up requiring companies to mitigate safety problems identified postmarket. Currently, mitigations such as new user training or new labeling can require rulemaking, which takes time and resources

We'll consider regulatory options to speed up requiring companies to mitigate safety problems identified postmarket. Currently, mitigations such as new user training or new labeling can require rulemaking, which takes time and resources

We'll consider regulatory options to speed up requiring companies to mitigate safety problems identified postmarket. Currently, mitigations such as new user training or new labeling can require rulemaking, which takes time and resources

FDA - U.S. Food and Drug Administration